C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 209/44 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) C07D 207/26 (2006.01) C07D 207/40 (2006.01) C07D 209/46 (2006.01) C07D 209/48 (2006.01) C07D 211/76 (2006.01) C07D 401/06 (2006.01) C07D 403/06 (2006.01)
Patent
CA 2208671
Novel imides of the general formula (see above formula) are inhibitors of tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is 2- Phthalimido- 3-(3',4'-dimethoxyphenyl)propane.
Des imides nouveaux inhibent le facteur alpha de nécrose tumorale et sont utiles pour combattre la cachexie, le choc endotoxique et la réplication rétrovirale. Un mode de réalisation typique est le 2-phtalimido-3-(3',4'-diméthoxyphényl)propane.
Muller George
Shire Mary
Stirling David I.
Celgene Corporation
Smart & Biggar
LandOfFree
Substituted imides as tnf inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imides as tnf inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imides as tnf inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1641980